clofibric acid has been researched along with Cirrhosis, Liver in 1 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dumortier, J | 1 |
| Slim, R | 1 |
| Chevallier, M | 1 |
| Boillot, O | 1 |
| Thaunat, JL | 1 |
| Vaillant, E | 1 |
| Vial, T | 1 |
| Bellemin, B | 1 |
| Paliard, P | 1 |
| Scoazec, JY | 1 |
1 other study available for clofibric acid and Cirrhosis, Liver
| Article | Year |
|---|---|
[Acute severe fibrosing hepatitis associated with ciprofibrate treatment].
Topics: Acute Disease; Aged; Chemical and Drug Induced Liver Injury; Clofibric Acid; Female; Fibric Acids; H | 1999 |